Prediction of response of skeletal metastases from cancer of the prostate to high activity 186Re HEDP therapy.

被引：0
|
作者：
McCready, VR
O'Sullivan, J
Dearnaley, D
Cook, G
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
[2] Inst Canc Res, Sutton, Surrey, England
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1272
引用
收藏
页码：316P / 316P
页数：1
相关论文
共 50 条
  • [41] Adverse Drug Reactions in Radiopharmaceutical Therapy for Bone Metastases: A Comprehensive Review of 89Sr, 153Sm, and 186Re Safety Reports from 1991 to 2022
    Jesus, A.
    Pinho, C.
    Martins, S.
    Martin-Suarez, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S924 - S924
  • [42] Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
    Ana M. Denis-Bacelar
    Sarah J. Chittenden
    David P. Dearnaley
    Antigoni Divoli
    Joe M. O’Sullivan
    V. Ralph McCready
    Bernadette Johnson
    Yong Du
    Glenn D. Flux
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 620 - 629
  • [43] Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
    Denis-Bacelar, Ana M.
    Chittenden, Sarah J.
    Dearnaley, David P.
    Divoli, Antigoni
    O'Sullivan, Joe M.
    McCready, V. Ralph
    Johnson, Bernadette
    Du, Yong
    Flux, Glenn D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) : 620 - 629
  • [44] A phase I study of combined docetaxel and repeated high activity rhenium-186-HEDP in castration-resistant prostate cancer metastatic to bone (the TAXIUM trial).
    van Dodewaard-de Jong, J. M.
    Bloemendal, H.
    de Klerk, J. M.
    van Bezooljen, B. P.
    de Haas, M. J.
    Wilson, R. H.
    O'sullivan, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Elevated activity of semicarbazide-sensitive amine oxidase in blood from patients with skeletal metastases of prostate cancer
    Ekblom, J
    Grönvall, J
    Lennernäst, B
    Nilsson, S
    Garpenstrand, H
    Oreland, L
    CLINICAL SCIENCE, 1999, 97 (01) : 111 - 115
  • [46] High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone
    J M O'Sullivan
    V R McCready
    G Flux
    A R Norman
    F M Buffa
    S Chittenden
    M Guy
    K Pomeroy
    G Cook
    J Gadd
    J Treleaven
    A Al-Deen
    A Horwich
    R A Huddart
    D P Dearnaley
    British Journal of Cancer, 2002, 86 : 1715 - 1720
  • [47] High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone
    O'Sullivan, JM
    McCready, VR
    Flux, G
    Norman, AR
    Buffa, FM
    Chittenden, S
    Guy, M
    Pomeroy, K
    Cook, G
    Gadd, J
    Treleaven, J
    Al-Deen, A
    Horwich, A
    Huddart, RA
    Dearnaley, DP
    BRITISH JOURNAL OF CANCER, 2002, 86 (11) : 1715 - 1720
  • [48] Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy:: Results from the Scandinavian Prostate Cancer Group study 5
    Jonler, M
    Nielsen, OS
    Groenvold, M
    Hedlund, PO
    Damber, L
    Hedelin, H
    Waldén, M
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (01): : 42 - 48
  • [49] Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
    Lopci, Egesta
    Lughezzani, Giovanni
    Fasulo, Vittorio
    Maffei, Davide
    Saita, Alberto
    Casale, Paolo
    Peschechera, Roberto
    Hurle, Rodolfo
    Benetti, Alessio
    Pasini, Luisa
    Zandegiacomo, Silvia
    Rodari, Marcello
    Zanca, Roberta
    Balzarini, Luca
    Guazzoni, Giorgio Ferruccio
    Buffi, Nicolo'
    Lazzeri, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 288 - 288
  • [50] IMPACT OF SKELETAL-RELATED EVENTS ON ANTI-TUMOR THERAPY PATTERN IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER
    Bhowmik, D.
    Shi, N.
    Manjelievskaia, J.
    Song, X.
    Vidito, S., I
    Intorcia, M.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
12345